You're visiting from outside the EU. Switch to the US version to see local pricing and tax details in USD.

Switch to US ($)
Contacto +33 (0)3 90 20 54 70

  • Mejora de la Desarrollabilidad de Anticuerpos

    Oumayma Rouis Oumayma Rouis 8 min read

    ¿Tiene un anticuerpo terapéutico candidato con características de fabricación subóptimas como bajo rendimiento, alta agregación o dificultades de purificación? Nuestro equipo dedicado de expertos en anticuerpos aprovecha…

  1. How the environment shapes immune system development during pregnancy

    Read more

  2. Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide

    Read more

  3. Gene Integration in Antibody Production: Overcoming Challenges for Optimal Clone Selection

    Read more

  4. A Guide to Choosing the Right CRO for Transient Recombinant Antibody Production

    Read more

  5. Humanized vs. Fully Human Antibodies: What’s the Difference?

    Read more

Cart (0 Items)

Your cart is currently empty.

View Products